BlackRock’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.4M | Sell |
|
|||||
|
2025
Q1 | $31M | Buy |
|
|||||
|
2024
Q4 | $39.3M | Buy |
|
|||||
|
2024
Q3 | $33.2M | Buy |
|
|||||
|
2024
Q2 | $32.8M | Buy |
|
|||||
|
2024
Q1 | $57.6M | Buy |
|
|||||
|
2023
Q4 | $50.1M | Buy |
|
|||||
|
2023
Q3 | $14.6M | Buy |
|
|||||
|
2023
Q2 | $15.2M | Buy |
|
|||||
|
2023
Q1 | $4.48M | Sell |
|
|||||
|
2022
Q4 | $5.87M | Buy |
|
|||||
|
2022
Q3 | $13.1M | Buy |
|
|||||
|
2022
Q2 | $12.3M | Buy |
|
|||||
|
2022
Q1 | $18.5M | Buy |
|
|||||
|
2021
Q4 | $17.6M | Buy |
|
|||||
|
2021
Q3 | $12.4M | Buy |
|
|||||
|
2021
Q2 | $10.2M | Buy |
|
|||||
|
2021
Q1 | $23K | Sell |
|
|||||
|
2020
Q4 | $662K | Sell |
|
|||||
|
2020
Q3 | $1.16M | Sell |
|
|||||
|
2020
Q2 | $1.75M | Sell |
|
|||||
|
2020
Q1 | $5.17M | Buy |
|
|||||
|
2019
Q4 | $7.81M | Buy |
|
|||||
|
2019
Q3 | $8.57M | Buy |
|
|||||
|
2019
Q2 | $7.6M | Buy |
|
|||||
|
2019
Q1 | $2.08M | Sell |
|
|||||
|
2018
Q4 | $2.33M | Buy |
|
|||||
|
2018
Q3 | $542K | Buy |
|
|||||
|
2018
Q2 | $304K | Buy |
|
|||||
|
2018
Q1 | $143K | Sell |
|
|||||
|
2017
Q4 | $136K | Buy |
|
|||||
|
2017
Q3 | $144K | Sell |
|
|||||
|
2017
Q2 | $212K | Buy |
|
|||||
|
2017
Q1 | $186K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $19K | Buy |
|